Is this the end of the road for the Cineworld share price?

Rupert Hargreaves explains why he thinks the outlook for the Cineworld share price has become too uncertain in the past few days.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Stack of one pound coins falling over

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

A little over a week ago, I wrote an article on the Cineworld (LSE: CINE) share price, exploring the outlook for the stock in 2022. 

In it, I concluded I was cautiously optimistic for the year ahead, based on recent consumer spending data. I speculated that if consumer spending continues to grow, the company could start to make a dent in its debt pile and move on from the pandemic. 

Since then, a lot has changed. New pandemic restrictions have dented consumer confidence, and a court ruling in the US has put the company’s very future at stake. 

The Cineworld share price slumps

Yesterday, the company revealed in a stock exchange announcement that the Ontario Superior Court of Justice had awarded substantial damages to the Cineplex chain of cinemas regarding the merger agreement between the two entities, which fell apart in June of last year. 

Cineworld initially terminated the merger agreement as the transaction no longer made sense during the pandemic. That seemed to be the right decision at the time. With the company fighting for its life, the last thing Cineworld needed was more debt and more screens to manage. 

However, Cineplex has argued that Cineworld breached the terms of its agreement by withdrawing. The two parties have levied several accusations against each other, resulting in a court battle. 

The court has now found in favour of Cineplex. It has awarded the company damages of C$1.2bn for lost synergies to Cineplex and C$5.5m for lost transaction costs. At current exchange rates, this judgement could cost Cineworld £700m. The firm’s current market capitalisation is just £623m. 

Cineworld has said it will appeal the judgement. In the meantime, it will not be paying any settlement. 

A threat to survival

I think this judgement could threaten the company’s survival. Not only could the business be on the hook for more than £700m in legal penalties, but it is also responsible for £3.5bn of other debts. 

Even though it is appealing the judgement, Cineworld’s legal battles may make it harder for the corporation to find new financing and sustain its current obligations.

Creditors may baulk at the idea of providing the company with more funding if it is at risk of having to pay what can only be described as a vast sum to Cineplex. It could be the end of the road for the Cineworld share price if it pulls the plug. 

Having said all of the above, in the background, it is clear that the company’s trading outlook is improving. Although recent restrictions will impact consumer confidence, it seems likely Cineworld will be able to capitalise on the economic recovery over the next 12 months. This will provide the establishment with much-needed cash flow to service its debts.

If the recovery is more robust than expected, it may also convince creditors to provide the business with more capital. So there is a chance the company could escape from its current predicaments. 

However, considering the scale of the company’s challenges, I am no longer interested in buying the stock. I think the potential risks of owning the shares are now are higher than the potential rewards. And there are plenty of other attractive investments for me to buy. 

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Rupert Hargreaves has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »